Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DYRK1A | Q13627 | 3/20 | 0.51 |
| ▸ | CLK1 | P49759 | 2/20 | 0.51 |
| ▸ | CDK4 | P11802 | 7/20 | 0.47 |
| ▸ | CCND1 | P24385 | 7/20 | 0.47 |
| ▸ | KIF11 | P52732 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | GABRP | O00591 | 2/20 | 0.44 |
| ▸ | GABRD | O14764 | 2/20 | 0.44 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.44 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.44 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.44 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.44 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.44 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.44 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.44 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.44 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.44 |
| ▸ | GABRE | P78334 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17207349 | 0.88 | DYRK1A (0.48) | DYRK1ACLK1CDK4CCND1KIF11 | |
| SCHEMBL19632180 | 0.79 | DYRK1A (0.46) | DYRK1ACLK1CDK4CCND1KIF11 | |
| SCHEMBL4048399 | 0.79 | DYRK1A (0.51) | DYRK1ACLK1CDK4CCND1KIF11 | |
| SCHEMBL24562418 | 0.79 | DYRK1A (0.51) | DYRK1ACLK1CDK4CCND1KIF11 | |
| SCHEMBL29755092 | 0.77 | CDK4 (0.51) | CDK4CCND1KIF11MEN1MAPT | |
| SCHEMBL28770596 | 0.77 | CDK4 (0.51) | CDK4CCND1KIF11MEN1MAPT | |
| SCHEMBL24731725 | 0.77 | AXL (0.44) | DYRK1ACLK1CDK4CCND1GABRA1 | |
| SCHEMBL17207905 | 0.76 | GABRP (0.43) | DYRK1ACLK1CDK4CCND1KIF11 | |
| SCHEMBL2627612 | 0.75 | CHEK1 (0.47) | DYRK1ACLK1CDK4CCND1MEN1 | |
| SCHEMBL2627611 | 0.74 | CDK4 (0.65) | DYRK1ACLK1CDK4CCND1KIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220255013-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2022-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220255013-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | SLCO4C1, SLCO2A1, SLCO2B1 | DYRK1A 4785/4885CLK1 4196/4885CDK4 3088/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.